Literature DB >> 26656085

Spare the rods and spoil the retina: revisited.

S Sivaprasad1, G Arden1.   

Abstract

Visual function improves with oxygen inhalation in people with diabetes even in the absence of visible retinopathy. Rods consume the most oxygen in the retina due to the high metabolic activity required to maintain the dark current. Therefore, Arden hypothesized that in diabetes where oxygen supply may also be affected due to the changes in retinal vasculature, prevention of dark adaptation may be a viable option to prevent or decrease the rate of progression of diabetic retinopathy. Animal experiments have proven that the absence of rods decreases the development of retinal neovascularisation. The same principle applies to panretinal photocoagulation, an established treatment for proliferative diabetic retinopathy. Recently, a few clinical studies have also shown that preventing dark adaptation by suppressing rods with 500-nm light source at night decreases the rate of progression of early diabetic retinopathy and maculopathy in the short-term. We await the results of a large two-year multi-centre trial (CLEOPATRA trial) to evaluate the long-term effects of decreasing dark adaptation by applying a 500nm light source as a mask over eyes with non-central diabetic macular oedema.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26656085      PMCID: PMC4763134          DOI: 10.1038/eye.2015.254

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  38 in total

1.  The effect of photocoagulation in ischemic areas to prevent recurrence of diabetic macular edema after intravitreal bevacizumab injection.

Authors:  Yoshihiro Takamura; Takeshi Tomomatsu; Takehiro Matsumura; Shogo Arimura; Makoto Gozawa; Yuji Takihara; Masaru Inatani
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-15       Impact factor: 4.799

2.  Hyperoxia, hyperglycemia, and photoreceptor sensitivity in normal and diabetic subjects.

Authors:  Anne Kurtenbach; Helmut M Mayser; Herbert Jägle; Andreas Fritsche; Eberhart Zrenner
Journal:  Vis Neurosci       Date:  2006 May-Aug       Impact factor: 3.241

3.  Prevalence of obstructive sleep apnoea in men with type 2 diabetes.

Authors:  S D West; D J Nicoll; J R Stradling
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

4.  Hyperoxia improves contrast sensitivity in early diabetic retinopathy.

Authors:  A Harris; O Arend; R P Danis; D Evans; S Wolf; B J Martin
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

5.  Effect of darkness on inner retinal hypoxia in diabetes.

Authors:  N Drasdo; Z Chiti; D R Owens; R V North
Journal:  Lancet       Date:  2002-06-29       Impact factor: 79.321

Review 6.  Retinal oxygen: fundamental and clinical aspects.

Authors:  Norbert D Wangsa-Wirawan; Robert A Linsenmeier
Journal:  Arch Ophthalmol       Date:  2003-04

7.  Mathematical models of the spatial distribution of retinal oxygen tension and consumption, including changes upon illumination.

Authors:  L M Haugh; R A Linsenmeier; T K Goldstick
Journal:  Ann Biomed Eng       Date:  1990       Impact factor: 3.934

Review 8.  Effect of obstructive sleep apnea on type 2 diabetes mellitus: A comprehensive literature review.

Authors:  Srikant Nannapaneni; Kannan Ramar; Salim Surani
Journal:  World J Diabetes       Date:  2013-12-15

9.  Oxygen distribution and consumption in the cat retina during normoxia and hypoxemia.

Authors:  R A Linsenmeier; R D Braun
Journal:  J Gen Physiol       Date:  1992-02       Impact factor: 4.086

10.  A multicentre phase III randomised controlled single-masked clinical trial evaluating the clinical efficacy and safety of light-masks at preventing dark-adaptation in the treatment of early diabetic macular oedema (CLEOPATRA): study protocol for a randomised controlled trial.

Authors:  Sobha Sivaprasad; Geoffrey Arden; A Toby Prevost; Roxanne Crosby-Nwaobi; Helen Holmes; Joanna Kelly; Caroline Murphy; Gary Rubin; Joanna Vasconcelos; Philip Hykin
Journal:  Trials       Date:  2014-11-22       Impact factor: 2.279

View more
  10 in total

Review 1.  Retinal oxygen: from animals to humans.

Authors:  Robert A Linsenmeier; Hao F Zhang
Journal:  Prog Retin Eye Res       Date:  2017-01-18       Impact factor: 21.198

2.  Hypoxic drive caused type 3 neovascularization in a preclinical model of exudative age-related macular degeneration.

Authors:  Lijuan Zhang; Xuan Cui; Yangjun Han; Karen Sophia Park; Xiaohong Gao; Ximei Zhang; Zhigang Yuan; Yong Hu; Chun-Wei Hsu; Xiaorong Li; Alexander G Bassuk; Vinit B Mahajan; Nan-Kai Wang; Stephen H Tsang
Journal:  Hum Mol Genet       Date:  2019-10-15       Impact factor: 6.150

3.  Correlation of Optical Coherence Tomography Angiography Characteristics with Visual Function to Define Vision-Threatening Diabetic Macular Ischemia.

Authors:  Wei-Shan Tsai; Sridevi Thottarath; Sarega Gurudas; Piyali Sen; Elizabeth Pearce; Andrea Giani; Victor Chong; Chui Ming Gemmy Cheung; Sobha Sivaprasad
Journal:  Diagnostics (Basel)       Date:  2022-04-22

Review 4.  Do photoreceptor cells cause the development of retinal vascular disease?

Authors:  Timothy S Kern
Journal:  Vision Res       Date:  2017-05-08       Impact factor: 1.886

5.  Measurement of dark adaptometry during ISCEV standard flash electroretinography.

Authors:  Jeff Rabin; Brooke Houser; Carolyn Talbert; Rue Patel
Journal:  Doc Ophthalmol       Date:  2017-10-03       Impact factor: 2.379

6.  Flavin homeostasis in the mouse retina during aging and degeneration.

Authors:  Tirthankar Sinha; Mustafa Makia; Jianhai Du; Muna I Naash; Muayyad R Al-Ubaidi
Journal:  J Nutr Biochem       Date:  2018-09-15       Impact factor: 6.048

7.  Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial.

Authors:  Sobha Sivaprasad; Joana C Vasconcelos; A Toby Prevost; Helen Holmes; Philip Hykin; Sheena George; Caroline Murphy; Joanna Kelly; Geoffrey B Arden
Journal:  Lancet Diabetes Endocrinol       Date:  2018-03-05       Impact factor: 32.069

Review 8.  Dyslipidemia in retinal metabolic disorders.

Authors:  Zhongjie Fu; Chuck T Chen; Gael Cagnone; Emilie Heckel; Ye Sun; Bertan Cakir; Yohei Tomita; Shuo Huang; Qian Li; William Britton; Steve S Cho; Timothy S Kern; Ann Hellström; Jean-Sébastien Joyal; Lois Eh Smith
Journal:  EMBO Mol Med       Date:  2019-09-05       Impact factor: 14.260

9.  Retinal and Choroidal Effects of Continuous Positive Airway Pressure as Treatment for Sleep Apnea: Results at 12 Months.

Authors:  Pedro Naranjo-Bonilla; Rafael Giménez-Gómez; María Del Carmen Muñoz-Villanueva; Bernabé Jurado-Gámez
Journal:  Int J Environ Res Public Health       Date:  2022-10-03       Impact factor: 4.614

10.  Effects of emixustat hydrochloride in patients with proliferative diabetic retinopathy: a randomized, placebo-controlled phase 2 study.

Authors:  Ryo Kubota; Chirag Jhaveri; John M Koester; Jeffrey K Gregory
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-27       Impact factor: 3.117

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.